celecoxib has been researched along with Bleeding in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effectiveness and adverse effects of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) for the primary or secondary prevention of dementia." | 9.05 | Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. ( Devane, D; Jordan, F; Kelly, JP; McGuinness, B; Murphy, K; Passmore, P; Quinn, TJ; Tudur Smith, C, 2020) |
| "During approximately 1063 months of exposure to both celecoxib and warfarin, 10 bleeding complications were identified, only one of which was considered major." | 7.73 | Bleeding complications in patients on celecoxib and warfarin. ( Bush, TM; Chakravarty, EF; Chung, L; Kearns, P; Wang, C, 2005) |
| " The authors encountered extensive bleeding in a patient receiving warfarin for anticoagulation after the introduction of celecoxib, an anti-inflammatory drug." | 7.72 | Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication. ( Atac, B; Daly, AK; Gupta, S; Malhi, H, 2004) |
| "Celecoxib is a selective COX-2 inhibitor and has a lower effect of platelet aggregation compared with conventional non-steroidal anti-inflammatory drugs (NSAIDs)." | 5.43 | A Comparison of Analgesic Effect between Loxoprofen and Celecoxib and the Frequency of the Hemorrhage Following Tonsillectomy. ( Ariki, M; Fukushima, N; Hirai, T; Miyahara, N; Yoshiga, A, 2016) |
| "To evaluate the effectiveness and adverse effects of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) for the primary or secondary prevention of dementia." | 5.05 | Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia. ( Devane, D; Jordan, F; Kelly, JP; McGuinness, B; Murphy, K; Passmore, P; Quinn, TJ; Tudur Smith, C, 2020) |
| " Thus, physiological and pathophysiological roles of COX-2 were considered from the standpoint of clinical effects of the two latest COX-2 selective inhibitors, celecoxib and rofecoxib, on inflammation, pain, fever and colorectal cancer together with their adverse effects on gastrointestinal, renal and platelet functions; and the usefulness and limits of COX-2-selective inhibitors were discussed with the trends of new NSAIDs development." | 4.81 | [Cyclooxygenase (COX)-2 selective inhibitors: aspirin, a dual COX-1/COX-2 inhibitor, to COX-2 selective inhibitors]. ( Nakamura, H, 2001) |
| " In a cohort study comparing the risk of upper gastrointestinal complications in celecoxib or traditional NSAIDs (diclofenac, ibuprofen) initiators with rheumatoid arthritis and osteoarthritis, we (1) aggregated medications and International Classification of Diseases-9 (ICD-9) diagnoses into hierarchies of the Anatomical Therapeutic Chemical classification (ATC) and the Clinical Classification Software (CCS), respectively, and (2) sampled the full cohort using techniques validated by simulations to create 9,600 samples to compare 16 aggregation scenarios across 50% and 20% samples with varying outcome incidence and exposure prevalence." | 3.79 | Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example. ( Beach, KJ; Brookhart, MA; Layton, JB; Le, HV; Poole, C; Schoenbach, VJ; Stürmer, T, 2013) |
| "During approximately 1063 months of exposure to both celecoxib and warfarin, 10 bleeding complications were identified, only one of which was considered major." | 3.73 | Bleeding complications in patients on celecoxib and warfarin. ( Bush, TM; Chakravarty, EF; Chung, L; Kearns, P; Wang, C, 2005) |
| " The authors encountered extensive bleeding in a patient receiving warfarin for anticoagulation after the introduction of celecoxib, an anti-inflammatory drug." | 3.72 | Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication. ( Atac, B; Daly, AK; Gupta, S; Malhi, H, 2004) |
| "Celecoxib is a selective COX-2 inhibitor and has a lower effect of platelet aggregation compared with conventional non-steroidal anti-inflammatory drugs (NSAIDs)." | 1.43 | A Comparison of Analgesic Effect between Loxoprofen and Celecoxib and the Frequency of the Hemorrhage Following Tonsillectomy. ( Ariki, M; Fukushima, N; Hirai, T; Miyahara, N; Yoshiga, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jordan, F | 1 |
| Quinn, TJ | 1 |
| McGuinness, B | 1 |
| Passmore, P | 1 |
| Kelly, JP | 1 |
| Tudur Smith, C | 1 |
| Murphy, K | 1 |
| Devane, D | 1 |
| Hirai, T | 1 |
| Fukushima, N | 1 |
| Miyahara, N | 1 |
| Yoshiga, A | 1 |
| Ariki, M | 1 |
| Le, HV | 1 |
| Poole, C | 1 |
| Brookhart, MA | 1 |
| Schoenbach, VJ | 1 |
| Beach, KJ | 1 |
| Layton, JB | 1 |
| Stürmer, T | 1 |
| Malhi, H | 1 |
| Atac, B | 1 |
| Daly, AK | 1 |
| Gupta, S | 1 |
| Chung, L | 1 |
| Chakravarty, EF | 1 |
| Kearns, P | 1 |
| Wang, C | 1 |
| Bush, TM | 1 |
| Aimbire, F | 1 |
| Lopes-Martins, RA | 1 |
| Albertini, R | 1 |
| Pacheco, MT | 1 |
| Castro-Faria-Neto, HC | 1 |
| Martins, PS | 1 |
| Bjordal, JM | 1 |
| Nakamura, H | 1 |
3 reviews available for celecoxib and Bleeding
| Article | Year |
|---|---|
Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Age | 2020 |
Celecoxib safety revisited.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cli | 2016 |
[Cyclooxygenase (COX)-2 selective inhibitors: aspirin, a dual COX-1/COX-2 inhibitor, to COX-2 selective inhibitors].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Clinical Trials as Topic; Colo | 2001 |
5 other studies available for celecoxib and Bleeding
| Article | Year |
|---|---|
A Comparison of Analgesic Effect between Loxoprofen and Celecoxib and the Frequency of the Hemorrhage Following Tonsillectomy.
Topics: Adult; Analgesics; Celecoxib; Female; Hemorrhage; Humans; Male; Pain, Postoperative; Phenylpropionat | 2016 |
Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example.
Topics: Adolescent; Adult; Aged; Algorithms; Arthritis; Celecoxib; Confounding Factors, Epidemiologic; Cyclo | 2013 |
Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthralgia; Aryl Hydrocarbon Hydroxyl | 2004 |
Bleeding complications in patients on celecoxib and warfarin.
Topics: Aged; Anticoagulants; Celecoxib; Cyclooxygenase 2 Inhibitors; Databases, Factual; Drug Interactions; | 2005 |
Effect of low-level laser therapy on hemorrhagic lesions induced by immune complex in rat lungs.
Topics: Animals; Anti-Inflammatory Agents; Celecoxib; Dexamethasone; Hemorrhage; Immune Complex Diseases; Lo | 2007 |